External resources PubMed: AOD 9604 lipolytic activity study - Research on AOD 9604 mechanism of action in adipose tissue New England Journal of Medicine: STEP 1 Trial - Landmark semaglutide weight loss trial with 1,961 participants FDA: Semaglutide safety information - Official FDA information on approved semaglutide formulations WADA Prohibited List - Current prohibited substances list including growth hormone fragments ClinicalTrials.gov: Semaglutide trials - Registry of ongoing and completed semaglutide clinical trials Choosing between AOD 9604 and semaglutide is ultimately a decision that depends on your individual circumstances, health status, and weight loss goals
It is also formulated with a focus on purity, using non-GMO ingredients and avoiding the common additives found in many retail brands
Cycling strategies vary by peptide and by the overall goals of the protocol
This suggests a potential strategy: use BPC-157 immediately post-training for tissue support, delay cryotherapy by 1-2 hours to preserve anabolic signaling, then apply cold therapy later for overnight recovery benefits
Long-term, lower level exposure results in cadmium accumulation in the kidneys and thyroid gland, and can contribute to thyroid issues, kidney disease, infertility, uterine fibroids, and other reproductive tract diseases if the build-up is high enough
